1 unchanged sentence
Director and Officer Trading Arrangements
−Removed: No directors or executive officers of the Company
−Removed: adopted , modified or terminated a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement (as defined in Item 408(c)
−Removed: of Regulation S-K) during the quarterly period covered by this Report.
+Added: No directors or executive officers of the Company adopted , modified or terminated a
+Added: Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement (as defined in Item 408(c) of Regulation S-K) during the quarterly
+Added: period covered by this Report.
+Added: Termination of Psilocybin License
+Added: On May 12, 2025, the Company delivered to
+Added: Arbormentis LLC a formal notice of termination of the Company’s License Agreement with Arbormentis LLC, ending the Company’s
+Added: participation in the previously announced psilocybin development program.
+Added: As a result of the cancellation, all obligations under the license
+Added: agreement with Arbormentis will cease as of the effective termination date, which is 90 days after the date of notice.
Copies of the following documents are included as exhibits to this
report pursuant to Item 601 of Regulation S-K
+Added: Title of Document
+Added: Asset Purchase Agreement between Relmada Therapeutics, Inc.
+Added: and Asarina Pharma AB, dated February 3, 2025
+Added: Incorporated by reference to Exhibit 10.1 to Current Report on Form
+Added: 8-K filed on February 6, 2025
+Added: Exclusive License Agreement between Trigone Pharma, Ltd., and Relmada Therapeutics, Inc., dated March 24, 2025†
+Added: Filed herewith
Certification of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
22 unchanged sentences
Filed herewith
−Removed: Exhibit attached to this Form 10-Q shall not be deemed “filed” for purposes of
−Removed: Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise
−Removed: subject to liability under that section, nor shall it be deemed incorporated by reference
−Removed: in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as
−Removed: expressly set forth by specific reference in such filing.
+Added: The Exhibit attached to this Form 10-Q shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to liability under that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.
+Added: Certain portions of this Exhibit have been redacted pursuant to Item 601(b)(10)(iv) of Regulation S-K.
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
−Removed: November 7, 2024
/s/ Sergio Traversa
9 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.